PI3K AS A THERAPEUTIC TARGET IN MALIGNANT PLEURAL MESOTHELIOMA

$316,000FY2012Department of the ArmyDOD

University Of Chicago, Chicago IL

Investigators

View source on USAspending →

PI3K AS A THERAPEUTIC TARGET IN MALIGNANT PLEURAL MESOTHELIOMA · GrantIndex